Use of semaglutide after acute coronary syndrome: an exploratory retrospective study
In this exploratory real-world cohort, initiating semaglutide at hospital discharge after ACS was feasible, well tolerated, and associated with high persistence and early cardiometabolic improvements.
Authors
- Marco Biasin (ORCID: https://orcid.org/0000-0002-4087-4840)
- M Stratinaki (ORCID: https://orcid.org/0000-0001-8720-1830)
- Alessia Gambaro (ORCID: https://orcid.org/0000-0001-8341-1427)
- D Betta
- N. Cordioli
- Ilaria Armani
- Luca Callegarin
- Giovanni Morani
- Sara De Giovanni
- George Aletras
Institutions
- University of Verona (IT)
- CTO Hospital (IT)
- The General Hospital of Heraklion "Venizeleio-Pananio" (GR)
Publication Details
- Journal
- Journal of Cardiovascular Medicine
- Published
- 2026-01-19
- DOI
- https://doi.org/10.2459/jcm.0000000000001837
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00